Perioperative use of statins in noncardiac surgery

Vascular Health and Risk Management

Volumn 4, Issue 1, 2008, Pages 75-81

  Chan, Y C ^a   Cheng, S W ^a   Irwin, M G ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cardiac complications; Morbidity; Mortality; Noncardiac surgery; Outcome; Perioperative; Statins; Vascular

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CHOLESTEROL; CREATINE KINASE; DOBUTAMINE; FLUINDOSTATIN; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; NITRIC OXIDE SYNTHASE; PLACEBO; PRAVASTATIN; SIMVASTATIN; TROPONIN T;

ANGIOGENESIS; ARTERY DISEASE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CAROTID ENDARTERECTOMY; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG WITHDRAWAL; ELECTIVE SURGERY; ELECTROCARDIOGRAM; EMERGENCY SURGERY; ENDOVASCULAR SURGERY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MEDLINE; MONOTHERAPY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PERIOPERATIVE COMPLICATION; PERIPHERAL VASCULAR DISEASE; PLEIOTROPY; QUALITY OF LIFE; REVIEW; RHABDOMYOLYSIS; SEPSIS; SIDE EFFECT; STRESS ECHOCARDIOGRAPHY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VASCULAR SURGERY;

HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; SURGICAL PROCEDURES, OPERATIVE; VASCULAR DISEASES;

EID: 41549166122     PISSN: 11766344     EISSN: None     Source Type: Journal    
DOI: 10.2147/vhrm.2008.04.01.75     Document Type: Review

References (75)

1. Abbruzzese TA, Havens J, Belkin M, et al. 2004. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg, 39:1178-85.
2. Abrams J. 2005. Clinical practice. Chronic stable angina. N Engl J Med, 352:2524-33.
3. Adesanya AO, de Lemos JA, Greilich NB, et al. 2006. Management of perioperative myocardial infarction in noncardiac surgical patients. Chest, 130:584-96.
4. ALLHAT. 2002. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA, 288:2998-3007.
5. Aronow HD, Topol EJ, Roe MT, et al. 2001. Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. Lancet, 357:1063-8.
6. Ashen MD, Blumenthal RS. 2005. Clinical practice. Low HDL cholesterol levels. N Engl J Med, 353:1252-60.
7. Ashton CM, Petersen NJ, Wray NP, et al. 1993. The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann Intern Med, 118:504-10.
8. Badner NH, Knill RL, Brown JE, et al. 1998. Myocardial infarction after noncardiac surgery. Anesthesiology, 88:572-8.
9. Bayly PJM, Matthews JNS, Dobson PM. et al. 2001. In-hospital mortality from abdominal aortic surgery in Great Britain and Ireland: Vascular Anaesthesia Society audit. BJS, 88:687-92.
10. Biccard BM, Sear JW, Foëx P. 2005. The pharmaco-economics of perioperative statin therapy. Anaesthesia, 60:1059-63.
11. Boden WE, O'Rourke RA, Teo KK, et al. 2007. COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med, 356:1503-16.
12. Bolsin S, Colson M, Conroy M. 2007. Beta-blockers and statins in noncardiac surgery. BMJ, 334:1283-4.
13. Boushra NN, Muntazar M. 2006. Review article: The role of statins in reducing perioperative cardiac risk: Physiologic and clinical perspectives. Can J Anaesth, 53:1126-47.
14. Chan AW, Bhatt DL, Chew DP, et al. 2002. Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention. Circulation, 105:691-6.
15. Cohen MC, Aretz TH. 1999. Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovasc Pathol, 8:133-9.
16. Collard CD, Body SC, Shernan SK, et al; Multicenter Study of Perioperative Ischemia (MCSPI) Research Group, Inc; Ischemia Research and Education Foundation (IREF) Investigators. 2006. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg, 132:392-400.
17. Devereaux PJ, Beattie WS, Choi PT, et al. 2005. How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ, 331:313-21.
18. Downs JR, Clearfield M, Weis S, et al. 1998. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA, 279:1615-22.
19. Dunkelgrun M, Schouten O, Feringa HH, et al. 2006. Beneficial effects of statins on perioperative cardiovascular outcome. Curr Opin Anaesthesiol, 19:418-22.
20. Durazzo AE, Machado FS, Ikeoka DT, et al. 2004. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg, 39:967-75.
21. Eagle KA, Rihal CS, Mickel MC, et al. 1997. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3,368 operations. CASS Investigators and University of Michigan Heart Care Program. Coronary Artery Surgery Study. Circulation, 96:1882-7.
22. Eisenberg DA. 1998. Cholesterol lowering in the management of coronary artery disease: the clinical implications of recent trials. Am J Med, 104(2A):2S-5S.
23. Erl W, Hristov M, Neureuter M, et al. 2003. HMG-CoA reductase inhibitors induce apoptosis in neointima-derived vascular smooth muscle cells, Atherosclerosis, 169:251-8.
24. Feringa HH, Bax JJ, Schouten O, et al. 2006. Protecting the heart with cardiac medication in patients with left ventricular dysfunction undergoing major noncardiac vascular surgery. Semin Cardiothorac Vasc Anesth, 10:25-31.
25. Feringa HH, Karagiannis SE, van Waning VH, et al. 2007. The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease. J Vasc Surg, 45:936-43.
26. Gibson CM, Ciaglo LN, Southard MC, et al. 2007. Diagnostic and prognostic value of ambulatory ECG (Holter) monitoring in patients with coronary heart disease: a review. J Thromb Thrombolysis, 23:135-45.
27. Grandy SM. 1988. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N Engl J Med, 319:24-33.
28. Heart Protection Study Collaborative Group. 2002. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360:23-33.
29. Heeschen C, Hamm CW, Laufs U, et al. 2003. Withdrawal of statins in patients with acute coronary syndromes. Circulation, 107:e27.
30. Henke PK, Blackburn S, Proctor MC, et al. 2004. Patients undergoing infrainguinal bypass to treat atheroscle-rotic vascular disease are underprescribed cardio-protective medications: effect on graft patency, limb salvage, and mortality. J Vasc Surg, 39:357-65.
31. Hindler K, Eltzschig HK, Fox AA, et al. 2006a. Influence of statins on perioperative outcomes. J Cardiothorac Vasc Anesth, 20:251-8.
32. Hindler K, Shaw AD, Samuels J, et al. 2006b. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology, 105:1260-72.
33. Imparato AM, Riles TS, Mintzer R, et al. 1983. The importance of hemorrhage in the relationship between gross morphologic characteristics and cerebral symptoms in 376 carotid artery plaques, Ann Surg, 197:195-203.
34. Kapoor AS, Kanji H, Buckingham J, et al. 2006. Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies. BMJ, 333:1149.
35. Kertai MD, Boersma E, Westerhout CM, et al. 2004. A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg, 28:343-52.
36. Kertai MD, Bogar L, Gal J, et al. 2006. Pre-operative coronary revascularization: an optimal therapy for high-risk vascular surgery patients? Acta Anaesthesiol Scand, 50:816-27.
37. Khanal S, Attallah N, Smith DE, et al. 2005. Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions. Am J Med, 118:843-9.
38. Koutouzis M, Nomikos A, Nikolidakis S, et al. 2007. Statin treated patients have reduced intraplaque angiogenesis in carotid endarterectomy specimens. Atherosclerosis, 192:457-63.
39. LaMuraglia GM, Stoner MC, Brewster DC, et al. 2005. Determinants of carotid endarterectomy anatomic durability: effects of serum lipids and lipid-lowering drugs. J Vasc Surg, 41:762-8.
40. Landesberg G, Mosseri M, Wolf YG, et al. 2003. Preoperative thallium scanning, selective coronary revascularization, and long-term survival after major vascular surgery. Circulaton, 108:177-83.
41. Le Manach Y, Godet G, Coriat P, et al. 2007. The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesth Analg, 104:1326-33.
42. Liao JK. 2005. Clinical implications for statin pleiotropy. Curr Opin Lipidol, 16:624-9.
43. Libby P. 2002. Inflammation in atherosclerosis. Nature, 420:868-74.
44. Lindenauer PK, Pekow P, Wang K, et al. 2004. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA, 291:2092-9.
45. LIPID Study Group. 1998. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med, 339:1349-57.
46. Mangano DT, Browner W, Hollenberg M, et al; for the Study of Perioperative Ischemia Research Group. 1992. Long-term cardiac prognosis following noncardiac surgery. JAMA, 268:233-9.
47. Mason RP, Walter MF, Jacob RF. 2004. Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress. Circulation, 109(21 Suppl 1):II34-II41.
48. McCarthy MJ, Loftus IM, Thompson MM, et al. 1999. Angiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque morphology. J Vasc Surg, 30:261-8.
49. McGown CC, Brookes ZL. 2007. Beneficial effects of statins on the microcirculation during sepsis: the role of nitric oxide. Br J Anaesthsia, 98:163-75.
50. Merx MW, Liehn EA, Graf J, et al. 2005. Statin treatment after onset of sepsis in a murine model improves survival. Circulation, 112:117-24.
51. Newby DE, Nimmo AF. 2004. Prevention of cardiac complications of noncardiac surgery: stenosis and thrombosis. Br J Anaesth, 92:628-32.
52. Noordzij PG, Poldermans D, Schouten O, et al. 2007. Beta-blockers and statins are individually associated with reduced mortality in patients undergoing noncardiac, nonvascular surgery. Coron Artery Dis, 8:67-72.
53. O'Neil-Callahan Y, Katsimaglis G, Tepper MR, et al. 2005. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. J Am Coll Cardiol, 45:336-42.
54. Paraskevas KI, Liapis CD, Hamilton G, et al. 2006. Can statins reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery? Eur J Vasc Endovasc Surg, 32:286-93.
55. Pasternack PF, Grossi EA, Baumann FG, et al. 1989. The value of silent myocardial ischemia monitoring in the prediction of perioperative myocardial infarction in patients undergoing peripheral vascular surgery. J Vasc Surg, 10:617-25.
56. Poldermans D, Bax JJ, Kertai MD, et al. 2003. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation, 107:1848-51.
57. Poldermans D, Bax JJ, Kertai MD, et al. 2003. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major non-cardiac vascular surgery. Circulation, 107:1848-51.
58. Poldermans D, Boersma E, Bax JJ, et al. 2001. Correlation of location of acute myocardial infarct after noncardiac vascular surgery with preoperative dobutamine echocardiographic findings. Am J Cardiol, 88:1413-14.
59. Poldermans D, Schouten O, Vidakovic R, et al.; DECREASE Study Group. 2007. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol, 49:1763-9.
60. Priebe HJ. 2004. Triggers of perioperative myocardial ischaemia and infarction. Br J Anaesth, 93:9-20.
61. [4S] Scandinavian Sinivastatin Study Group. 1994. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Sinivastatin Survival Study (4S). Lancet, 344:1383-9.
62. Sacks FM, Pfeffer MA, Moye LA, et al. 1996. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med, 335:1001-9.
63. Schouten O, Bax JJ, Dunkelgrun M, et al. 2006a. Statins for the prevention of perioperative cardiovascular complications in vascular surgery. J Vasc Surg, 44:419-24.
64. Schouten O, Kertai MD, Bax JJ, et al. 2005. Safety of perioperative statin use in high-risk patients undergoing major vascular surgery. Am J Cardiology, 95:658-60.
65. Schouten O, Kok NF, Boersma E, et al. 2006b. Effects of statins on renal function after aortic cross clamping during major vascular surgery. Am J Cardiol, 97:1383-5.
66. Schouten O, van Laanen JHH, Boersma E, et al. 2006c. Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg, 32:21-6.
67. Shepherd J, Blauw GJ, Murphy MB, et al. 2002. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet, 360:1623-30.
68. Spencer FA, Allegrone J, Goldberg RJ, et al; GRACE Investigators. 2004. Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. Ann Intern Med, 140:857-66.
69. Takemoto M, Liao JK. 2001. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol, 21:1712-19.
70. Tousoulis D, Antoniades C, Koumallos N, et al. 2006. Novel therapies targeting vascular endothelium. Endothelium, 13:411-21.
71. Ward RP, Leeper NJ, Kirkpatrick JN, et al. 2005. The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery. Int J Cardiol, 104:264-8.
72. Ward S, Lloyd Jones M, Pandor A, et al. 2007. A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess, 11:1-178.
73. Wong GTC, Irwin MG. 2007. Contrast induced nephropathy. Br J Anaesth, 99:474-83.
74. Xenos ES, Stevens SL, Freeman MB, et al. 2005. Nitric oxide mediates the effect of fluvastatin on intercellular adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 expression on human endothelial cells. Ann Vasc Surg, 19:386-92.
75. Zaman AG, Helft G, Worthley SG, et al. 2000. The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis, 149:251-66.